A Study of LAD603 in Adults With Alopecia Areata — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of LAD603 in Adults With Alopecia Areata — Stella

Recruiting

Back to Alopecia Areata trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Investigator Site 1, Omaha, Nebraska

Key details

Phase

Safety & dosing

Sponsor

Almirall, S.A.

Enrollment target

~136 participants

Started

December 2025

Primary completion

May 2027

Age range

18 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov